Quark to File IND for Eye Disease Rx in September; New Data Shows It May Treat Glaucoma

The drug's initial indication will be non-arteritic anterior ischemic optic neuropathy, a rare condition that can lead to permanent blindness, but the company expects to ultimately develop it as glaucoma therapy.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.